Chair’s Welcome

A welcome from Julie Pomeroy, the Non-Executive Chair of OCT

Welcome to OCT

Engaging with our investors is very important to us and we want you to be well briefed about the Company, its activities and its drug development programmes.

Whether you are an existing investor, are thinking about investing in our business, or are simply keen to learn more, we hope you will find the information contained here useful for getting a deeper insight into our Company, its organisation, business strategy and future plans.

Julie Pomeroy, Non-Executive Chair

Company
presentation